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Abstract 
Background: Cricopharyngeal dysfunction is a narrowing at the level of the upper oesophageal sphincter caused 
by failed or incomplete sphincter opening as a result of lack of pharyngoesophageal coordination or reduction in the 
muscular compliance of the upper oesophageal sphincter. Oropharyngeal dysphagia is a typical symptom. Videoma-
nometry allows direct comparison of pressure readings with dynamic anatomy during swallowing.
Methods: This is a prospective randomized pilot study that compares the effect of balloon dilatation and laser myot-
omy in cricopharyngeal dysfunction. We used videomanometry as an objective measure and the Swedish version of 
Sydney Swallowing Questionnaire as patient’s self-assessment at baseline and 1 and 6 months after treatment.
Results: The UES sagittal diameter increased from 5.6 mm pre-operatively to 8.4 mm 6 months post-operatively with 
no differences between treatment groups. Preoperative mean Sydney Swallowing Questionnaire score was 770 and 
6 months post-operative score 559, with no difference between the treatments in our cohort.
Conclusion: Cricopharyngeal dysfunction treatment by either laser myotomy or balloon dilatation improved upper 
oesophageal sphincter opening during at least 6 months.
Trial registration: ISRCTN84905610, date: 081214
Keywords: Cricopharyngeal dysfunction, Upper oesophageal sphincter, Cricopharyngeus muscle, Videomanometry, 
Sydney Swallowing Questionnaire
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Background
The pharyngoesophageal segment (PES) is made up of 
the inferior pharyngeal constrictor, the cricopharyngeus 
muscle (CPM) and the proximal part of the cervical 
oesophagus. The upper oesophageal sphincter (UES) is 
a 2.5–4.5 cm high-pressure zone visualized on manom-
etry between the pharynx and oesophagus. PES refers 
to anatomy and UES to function, but the terms are syn-
onymous. The CPM is 1–2 cm and it is a key component 
of the UES because it is the only portion that actively 
participates in all reflexive relaxation and tighten-
ing activities [1]. Cricopharyngeal dysfunction (CPD), 
characterized by oropharyngeal dysphagia, may be due 
to incoordination as well as reduction in maximal open-
ing of the UES during transphincteric flow [2, 3].
Radiological assessment of CPD can be challenging [3]. 
Videomanometry (VM) combining solid state manom-
etry and videofluoroscopy allows direct comparison of 
pressure readings with dynamic anatomy giving a better 
appreciation of how these readings are related to the pas-
sage of the bolus [4, 5].
The CPM is frequently targeted for intervention 
in CPD [6]. There are four approaches to the CPM, 
including: the external technique, which is indicated 
when a biopsy is needed; the endoscopic approach, 
which offers the choice of laser or the surgical stapler; 
bougie or balloon dilatation of the UES and botulinum 
toxin injection in the CPM endoscopically [7] or percu-
taneous [8]. In our department we use balloon dilata-
tion and laser myotomy to treat CPD without Zenker 
diverticulum.
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Aim of the study
This is a randomized and prospective pilot study to com-
pare the effects of balloon catheter dilatation (BD) and 
laser myotomy (LM) in CPD.
Methods
We included patients who had dysphagia due to CPD 
without Zenker diverticulum for more than 3  months 
and who had not undergone any previous interventions 
in the PES. They underwent clinical assessment by an 
otorhinolaryngologist. None of the patients had medi-
cal instability, cervical osteophytes, neurological dis-
eases, untreated reflux or hepatitis. All were informed 
about the benefits and risk of the procedures and signed 
an informed consent. After the CPD was confirmed by 
VM, they were randomized to LM or BD. The study was 
approved by the ethical committee of the University of 
Lund.
We evaluated the variables pre- and 1 and 6  months 
post-treatment using VM and the Swedish version of 
the Sydney Swallowing Questionnaire (SSQ) [9], a reli-
able and consistent instrument for the assessment of 
subjective dysphagia symptoms. The SSQ is a self-report 
inventory with a maximum possible total score of 1,700; 
it consists of 17 questions yielding a score of 0–100 for 
each.
Videomanometry was performed in frontal and lat-
eral projection with the patient seated. Videofluoros-
copy was done before inserting the manometry catheter, 
in order to measure the dimensions of the PES. Then a 
small amount of topic anaesthetic (Xylocain 2%; Astra 
Zeneca, Södertälje, Sweden) was placed in the nostril. 
The catheter was introduced through the nose to UES 
and oesophagus under fluoroscopic guidance in order to 
reduce patient discomfort. Time for examination was less 
than 10 min and total fluoroscopy within 100 s, radiation 
dose 0.3  mSv. All participants were instructed to swal-
low 10  ml of water-soluble contrast (Barium contrast 
medium, 240 mg/ml, Nycomed Imaging, Oslo, Norway) 
three times. Retention and penetration of the contrast as 
well as 20 variables were analysed by VM (Table 1).
The catheter’s diameter was 4.6  mm with four solid-
state pressure transducers positioned 2 cm apart (Konigs-
berg Instruments Inc. Pasadena, CA, USA). The proximal 
sensors were dorsal oriented to measure 120°, while the 
two distal transducers were circumferential, allowing 360° 
measurements. All sensors were radiopaque and easy to 
identify during fluoroscopy. The sampling frequency was 
64  Hz. The analogue signal was converted to a digital 
signal (Polygraf, SynMed Medicinteknik, Spånga; Swe-
den). The pressure values were registered in mmHg and 
referred to atmospheric pressure. The system was cali-
brated at 0 and 50 mmHg and carried out at 37°C [10].
Follow-up was made in an outpatient clinic 1 and 
6 months after treatment.
Flexible oesophagoscopy was conducted in all patients 
with reflux symptoms and they received proton pump 
inhibitors during 2 months preoperatively [11]. Myotomy, 
using CO2 laser, was performed under general anaesthe-
sia, according to the technique described by Lawson [12]. 
We used neither fibrin glue to the incision nor nasogas-
tric feeding tube to avoid interference with the healing 
process of the surgical field. During the first postopera-
tive 2 days the patients were fed parenterally. On day 3 a 
liquid and semisolid diet was authorized and the patient 
discharged. On day 10 normal diet was resumed. Preoper-
ative temperature, C-reactive protein (CRP), erythrocyte 
sedimentation rate (SR) and leucocytes were taken and 
the same procedure was performed 4  h after the opera-
tion and in the morning on days 2 and 3 after surgery.
Table 1 Videomanometry variables, all of them in sagittal 
projection except 1–3
Diameter is measured in mm and pressure in mm Hg. P-value = within subjects, 
P-value treat = difference between treatments. Maximal hyoid movement 
is hyoid’s elevation (=maximal hyoid movement 1) followed by a ventral 
movement (=maximal hyoid movement 2). The diagonal line between the 
resting position and maximal cranioventral movement is the maximal hyoid 
movement 3.
CPM cricopharyngeus muscle, Preop pre-operatively, Post1 1 month post-
operatively, Post2 6 months post-operatively, UES upper oesophageal sphincter.
Preop Post1 Post2 P value P-value 
treat
Frontal UES diam.by CPM 9.9 10.6 10.0 0.68 0.78
Frontal UES diam.15 mm  
over CPM
20.5 20.7 18.7 0.49 0.63
Frontal UES diam.15 mm  
under CPM
12.0 12.1 13.1 0.21 0.03
UES diam.by the CPM 5.6 7.6 8.4 0.008 0.86
UES diam.15 mm over CPM 13.3 15.2 16.7 0.05 0.29
UES diam.15 mm under CPM 9.6 9.9 11.5 0.16 0.39
Maximal hyoid movement 1 10.9 10.2 11.0 0.77 0.32
Maximal hyoid movement 2 12.5 14.5 16.3 0.11 0.28
Maximal hyoid movement 3 16.5 17.5 18.2 0.67 0.20
Maximal laryngeal elevation 21.4 22.7 24.5 0.61 0.36
Resting UES pressure 65.0 54.4 56.0 0.60 0.92
Residual pressure UES  
relax dry
3.0 1.3 2.5 0.42 0.54
Residual pressure UES  
relax wet
3.0 1.3 4.6 0.80 0.73
Duration of UES relax dry 0.5 0.5 0.5 0.68 0.85
Duration of UES relax wet 0.7 0.6 0.7 0.50 0.50
UES contraction pressure 280.0 275.0 293.0 0.95 0.60
Intrabolus pressure 49.0 34.0 – – –
Pharyngeal pressure 292.0 302.6 184.0 0.13 0.37
Tongue base pressure 261.0 241.0 187.0 0.02 0.63
Oesophagus amplitude 77.0 82.0 83.0 0.53 0.09
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Dilatation was performed with a controlled radial 
expansion balloon with diameter 18–20  mm, during 
2.5  min under general anaesthesia. Temperature and 
blood test including CRP, SR and leucocytes were taken 
preoperatively and 4 h postoperatively and in the morn-
ing on day 2. If these parameters were normal a liquid 
and semisolid diet was authorized and the patient dis-
charged. On days 5 to 7 normal diet was resumed.
Statistics
Data were processed with SPSS version 22 for Mac and 
statistical analysis was made using descriptive statistics 
and repeated measures ANOVA, p values <0.05(two-
tailed) were regarded as significant.
Results
Ten patients were included in the study, but only eight 
patients completed. The mean age was 74 years and the 
age range 67–81 years. Four participants were male and 
four female. After being randomized four were treated 
with BD and four with LM. No complications were 
reported.
The follow-up time was 1 and 6-months postopera-
tive with SSQ, VM and clinical control in the outpatient 
clinic.
SSQ
The response rate to SSQ was 100%. Mean SSQ score 
(Table  2) was pre-operative: 770 (CI 457–1,084) BD: 
691, LM: 850, 1 month post-operative: 340 (CI 74–606) 
BD: 398, LM: 281 and 6 months post-operative: 559 (CI 
212–906) BD: 718, LM: 399 indicating a statistical sig-
nificant improvement (p = 0.003) in self-reported swal-
lowing impairment, but we could not find a significant 
difference between the different treatments in our cohort 
(p = 0.72).
Highest pre-operative mean scores (50 or more) were 
registered in seven questions: difficulty in swallowing 
solid food (question 5), difficulty in swallowing dry food 
(question 6), food gets stuck in the throat (question 9), 
choke with solid food (question 10), swallowing more 
than once (question 14), dysphagia severity rate (question 
16) and quality of life (question 17). Post-operative mean 
scores decreased in all these questions, with values equal 
to 45 or less (Table 3).
Videomanometry
The UES sagittal diameter at the CPM increased if we 
considered both treatments, (p = 0.008): pre-operatively 
mean 5.6  mm (CI 4.1–6.9), BD: 5.6  mm, LM: 5.6  mm, 
1 month post-operatively mean 7.6 mm (CI 6.5–8.7), BD: 
7.2 mm, LM: 8 mm and 6 months post-operatively mean 
8.4 mm (CI 6.4–10.4), BD: 8.1 mm, LM: 8,7 mm, Figure 1, 
but we could not find a significant difference between the 
two treatments in our cohort (p = 0.86).
Tongue base pressure decreased (p =  0.02) from pre-
operatively: 261 mm Hg (CI 75.3–475) BD: 269 mm Hg, 
LM: 250  mm Hg, 1  month post-operatively: 241  mm 
Hg (CI 65.2–432.7) BD: 236  mm Hg, LM: 249  mm Hg, 
to 6  months post-operatively: 187 (CI 37.7–358.2) BD: 
178  mm Hg, LM: 200  mm Hg, without a difference 
between the treatments in our cohort (p = 0.63).
Table 2 Pre- and  post-treatment Sydney Swallowing 
Questionnaire´s mean total score presented by  case 
and treatment
BD balloon dilatation, LM laser myotomy, SSQ Sydney Swallowing Questionnaire, 
preop pre-operatively, post1 1 month post-operatively, post2 6 months post-
operatively.
Case Treatment SSQpreop SSQpost1 SSQpost2
1 BD 1,142 704 960
2 LM 1,131 756 744
3 BD 648 121 968
4 BD 240 78 86
5 BD 734 691 860
6 LM 1,217 235 736
7 LM 305 24 70
8 LM 748 111 48
Table 3 Pre- and  post-treatment Sydney Swallowing 
Questionnaire´s mean scores by question
SSQ Sydney Swallowing Questionnaire, preop pre-operatively total score, post1 
1 month post-operatively total score, post2 6 months post-operatively total 
score.
SSQ Score Preop Post1 Post2
1. Swallowing difficulty 36 17 40
2. Thin liquids 32 20 31
3. Thick liquids 26 20 34
4. Soft food 38 19 23
5. Hard food 64 18 42
6. Dry food 61 30 45
7. Swallowing saliva 23 12 17
8. Starting a swallow 47 17 34
9. Food stuck in the throat 65 28 45
10. Cough/choke with solids 60 22 40
11. Cough/choke with liquids 35 19 26
12. Time to eat a meal 33 28 30
13. Food/liquid behind nose 25 12 16
14. Swallow more than once 58 26 40
15. Cough/spit during a meal 44 20 28
16. Dysphagia severity rate 60 21 43
17. Quality of life 68 16 38
Total 770 340 559
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The pre-operative intrabolus pressure mean value, 
at the level of the inferior pharyngeal constrictor, was 
30  mmHg, because of technical reasons it could not be 
measured after 6  months in the last four patients and 
could therefore not be analysed.
Three patients (number 2, 5 and 8) had pre-operative 
subepiglottic penetration of the contrast in the VM, but 
none of them had it post-operatively. Three (number 3, 5 
and 6) had retention of the contrast in the vallecula pre- 
and postoperatively. The pre-operative oesophagus ampli-
tude mean was 77  mm Hg, 1-month post-operatively it 
was 82-mmHg and 6 months post-operatively 83 mmHg.
The following variables did not change post-opera-
tively: Frontal and sagittal diameter of UES, 15 mm over 
and under the CPM, pharyngeal pressure at the level of 
the constrictor inferior muscle, maximal hyoid move-
ment, laryngeal elevation, resting UES pressure, residual 
pressure during UES relaxation dry and wet, duration of 
UES relaxation dry and wet and UES contraction pres-
sure (Table 1).
Discussion
Most published studies on CPD treatment are small and 
retrospective, without randomization and/or control 
and a short follow-up. Our study is prospective and ran-
domised but with a limited sample size, thus the results 
should be interpreted with caution.
A postoperative improvement was seen for the SSQ 
score, UES sagittal diameter at CPM and tongue base 
pressure after BD and LM. Although we could not find a 
difference between the treatments in our cohort, patients 
1, 3 and 5 treated with BD had high 6 month-post SSQ 
scores, patients 3 and 5 had increased UES diameter at 
CPM only 0, 7  mm (Table  4) and these three partici-
pants had oropharyngeal dysphagia, made a new VM and 
required retreatment after 12 months: one with LM and 
two with new BD. None of the patients who underwent 
LM have been treated again.
The success rate of BD varies from 35 to 85% [13]. Con-
sidering SSQ and the UES sagittal diameter, the success 
rate for BD in our study was 100% after 1 month, but only 
50% after 6 months.
Balloon catheter dilatation protocols are not yet stand-















Figure 1 Upper oesophageal sphincter sagittal diameter at cricopharyngeal muscle. Preop pre-operatively, post1 1 month post-operatively, post2 
6 months post-operatively.
Table 4 Pre- and  post-treatment UES sagittal diameter 
at cricopharyngeal muscle
Measures are made in mm, during bolus passage in videofluoroscopy.
BD balloon dilatation, LM laser myotomy, UES upper oesophageal sphincter, 
preop pre-operatively, post1 1 month post-operatively, post2 6 months post-
operatively.
CASE Treatment UES preop UES post1 UES post2 UES post2- 
UES preop
1 BD 4.7 7.3 7.0 2.3
2 LM 8.3 9.5 10.0 1.7
3 BD 8.3 7.7 9.0 0.7
4 BD 4.7 7.7 11.0 6.3
5 BD 4.6 6.3 5.3 0.7
6 LM 5.3 5.6 6.5 1.2
7 LM 3.3 8.3 6.6 3.3
8 LM 5.3 8.6 12.0 6.7
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pressure of the balloon and the duration of each dilata-
tion varies and appears to be dependent upon the per-
sonal preference and the experience of the operator. 
The UES is kidney shaped which might explain why the 
dilatation with a cylindrical device only treats part of the 
sphincter effectively and why it is possible to introduce 
a 4.6  mm catheter when the sagittal diameter at CPM 
is only 3.3 mm [16–18, 19]. Cates el al. propose in their 
study that the circular model underestimates UES area 
by 60%. The largest dilator currently available for UES 
dilation is 20 mm. Belafsky et al. in a recent study show 
how the efficacy of the BD improves using two cylindri-
cal catheters instead of one and they propose a kidney 
shaped oesophageal dilator [17].
The success rate of myotomy by external approach or by 
endoscope is around 70% which is in accordance with our 
results [20]. The ability to recognize the buccopharyn-
geal fascia, the visceral layer of the middle layer of the 
deep cervical fascia with the endoscopic technique [21], 
explains the low rate of complications. We restrict the 
external approach to cases in which appropriate exposure 
is impossible to reach via the endoscopic approach.
After an initial compensatory increase of tongue base, 
intrabolus and pharyngeal pressure at the inferior constric-
tor, the pharynx becomes progressively dilated and weak 
proximal to the obstruction as the severity of CPD increases 
[10]. Frontal and sagittal diameter of UES 15 mm over and 
under the CPM, pharyngeal pressure at the level of constric-
tor inferior muscle, maximal hyoid movement, laryngeal 
elevation, resting UES pressure, residual pressure during 
UES relaxation dry and wet, duration of UES relaxation dry 
and wet, UES contraction pressure, did not show any post-
operative changes in our cohort (Table 1). These data sug-
gest that once the diagnosis is made, if the comorbidity and 
functional status of the patient allows the intervention, it 
should be done before the pharyngeal weakness is irrevers-
ible. The length of time over which this may occur is still 
unknown and is in an area of continuing research [22].
In order to analyse pre- and post-operative changes in 
UES, we should measure cross sectional dimensions as 
well, which is not feasible by VM. High-resolution manom-
etry combining oesophageal and pharyngeal impedance 
and ph-monitoring improves the diagnosis accuracy in the 
PES and future studies should use these techniques.
Conclusion
According to measures with both VM and SSQ, LM 
improves UES opening in 100% and BD in 50% of the 
patients in our study during at least 6  months. Earlier 
CPD treatment might relieve symptoms before pharyn-
geal dimensions change and help to prevent irreversible 
pharyngeal dilatation and weakness. The success of the 
procedure is strongly related to the selection of patients.
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